| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $113.2M | +77.7% |
| SG&A Expense | $36.2M | +62.0% |
| Operating Income | -$149.5M | -73.6% |
| Net Income | -$126.2M | -54.2% |
| EPS (Basic) | -$2.17 | -31.5% |
| EPS (Diluted) | -$2.17 | -31.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $335.4M | +38.7% |
| Short-term Investments | $384.5M | +66.9% |
| Current Assets | $726.5M | +52.0% |
| Total Assets | $732.4M | +51.8% |
| Current Liabilities | $31.8M | +63.4% |
| Total Liabilities | $31.8M | +63.4% |
| Stockholders' Equity | $700.6M | +51.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$99.7M | -53.5% |
| Investing Cash Flow | -$143.5M | -1245.8% |
| Financing Cash Flow | $336.8M | +35.3% |